Background and Objectives: The long history of traditional medicine clearly demonstrates the role of nutrition in the prevention and treatment of the disease. Of particular importance in modern scientific medicine is the simultaneous use natural biologically active complexes and mediccines. The objective of this study is to provide clinical evidence of the effectiveness and functional orientation of a new type of biologically active additives (BAA) in the patients with vegetative vascular dystonia and chronic cerebrovascular disorder. Methodology: The principles of the modern science of nutrition on the role of individual macro-and micronutrients, and minor components of food in the correction of metabolic disorders form the methodological basis of the research. Results: The biologically active additive "Sophia" was introduced in the diet of the patients for 4 weeks at a dose of one tablet, in combination with 50 mg of Trental per day (the 1st main group). The 2nd main group received an additional "Guta-Viva" additive. The 3rd (control) group received Trental only, at the prescribed dosage. The use of BAA had a positive effect on the relief of disease syndromes, and improved overall health. Conclusion: The antioxidant effect of the specialized product, as well as the improvement of metabolic processes in the brain, was noted. A conclusion was made that the test product can be an effective remedy in the treatment of moderately grave vegetative-vascular dystonia. BAA is well tolerated by the patients and does not cause side effects.
IJPRAS
